Nanjing Hicin Pharmaceutical Co., Ltd.

¥31.83As of Sun 8 Nov 2026, 12:00 UTC
SZSE:300584Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR 2.00%
Div yield 0.31%
ROE 7.06%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.10
PE TTM 53.31
TSR TTM (47.96%)
Mkt cap ¥3.820B
ROIC 7.35%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥34
5.93%
122.09%
Hold 9|12|12|12|3
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.35
0.38
0.41
0.40
14.58%
26.49%
25.24%
21.31%
Revenue¥M
232.0
226.7
222.1
219.7
2.06%
(0.87%)
(3.60%)
(7.08%)
Peers (US$572.6M)
Cap (US$)
PE
575.6M
26.66x
Capital
TTM
5Y
10Y
Leveragex
1.009
(0.053)
(0.046)
EBIT/Intx
3.458
0.310
0.280
Own earn%
11.29
115.38
145.15
Sh yield%
34.18
43.69
42.18
Owners
Insiders/Inst%
1.71
20.12
Short interest%
0.52
SBC / revenue%
0.41
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
0–6
$1 testx
—
Incr. ROIC%
4